|
|
Volumn 1, Issue 3, 2004, Pages 129-135
|
|
The emerging role of natriuretic peptides in the diagnosis and treatment of decompensated heart failure.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL MARKER;
NATRIURETIC FACTOR;
NERVE PROTEIN;
PREPRO BRAIN NATRIURETIC PEPTIDE;
PREPRO-BRAIN NATRIURETIC PEPTIDE;
PROTEIN PRECURSOR;
ADULT;
AGED;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONGESTIVE HEART FAILURE;
CONTROLLED CLINICAL TRIAL;
FEMALE;
HEART FUNCTION TEST;
HOSPITALIZATION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
METABOLISM;
MIDDLE AGED;
MORTALITY;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
SURVIVAL RATE;
TREATMENT OUTCOME;
ADULT;
AGED;
BIOLOGICAL MARKERS;
FEMALE;
HEART FAILURE, CONGESTIVE;
HEART FUNCTION TESTS;
HUMANS;
INFUSIONS, INTRAVENOUS;
MALE;
MIDDLE AGED;
NATRIURETIC PEPTIDES;
NERVE TISSUE PROTEINS;
PROGNOSIS;
PROTEIN PRECURSORS;
RANDOMIZED CONTROLLED TRIALS;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
SEVERITY OF ILLNESS INDEX;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
|
EID: 23944464991
PISSN: 15469530
EISSN: None
Source Type: Journal
DOI: 10.1007/s11897-004-0022-7 Document Type: Review |
|
Times cited : (5)
|
|
References (39)
|
